Pubblicazioni

Letter to the editor: Serum thrombospondin-2 as biomarker in liver diseases, a look beyond NASH

2022 - HEPATOLOGY

Colasanti, T.; Di Giamberardino, A.; Grimaldi, A.; Cardinale, V.; Carpino, G.; Mancone, C.

Letter to the editor: Episodic-precipitantâinduced hepatic encephalopathy treatment: Look at new and old precipitants!

2022 - HEPATOLOGY

Ridola, L.; Nardelli, S.; Gioia, S.; Faccioli, J.; Riggio, O.

Reply

2021 - HEPATOLOGY

Lamarca, A.; Santos-Laso, A.; Utpatel, K.; La Casta, A.; Stock, S.; Forner, A.; Adeva, J.; Folseraas, T.; Fabris, L.; Macias, R. I. R.; Krawczyk, M.; Krawczyk, M.; Cardinale, V.; Braconi, C.; Alvaro, D.; Evert, M.; Banales, J. M.; Valle, J. W.

Letter to the Editor: Focal Adhesion Kinase/Î²-Catenin Network May Act as a Regulator of Hepatocellular Carcinoma Epigenetics

2019 - HEPATOLOGY

Romito, I.; Panera, N.; D'Ermo, G.; Alisi, A.

Reply

2018 - HEPATOLOGY

Lai, Quirino; Vitale, Alessandro

Prediction of hepatic encephalopathy: Why disregard well-known risk factors?

2018 - HEPATOLOGY

Ridola, L.; Riggio, O.

Pubblicazioni

Letter to the editor: Serum thrombospondin-2 as biomarker in liver diseases, a look beyond NASH

Letter to the editor: Episodic-precipitantâinduced hepatic encephalopathy treatment: Look at new and old precipitants!

Reply

Letter to the Editor: Focal Adhesion Kinase/Î²-Catenin Network May Act as a Regulator of Hepatocellular Carcinoma Epigenetics

Reply

Prediction of hepatic encephalopathy: Why disregard well-known risk factors?

Letter to the editor: Episodic-precipitantâinduced hepatic encephalopathy treatment: Look at new and old precipitants!